Comparison between GNH India Pharmaceuticals IPO and Indus Net Technologies IPO.
GNH India Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Indus Net Technologies IPO is a SME Bookbuilding proposed to list at NSE SME.
| GNH India Pharmaceuticals IPO | Indus Net Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | MAS Services Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of GNH India Pharmaceuticals IPO is up to ₹0.00 Cr whereas the issue size of the Indus Net Technologies IPO is up to ₹0.00 Cr. The final issue price of GNH India Pharmaceuticals IPO is and of Indus Net Technologies IPO is .
| GNH India Pharmaceuticals IPO | Indus Net Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 37,00,000 shares | 36,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 37,00,000 shares | 36,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
GNH India Pharmaceuticals IPO opens on , while Indus Net Technologies IPO opens on . The closing date of GNH India Pharmaceuticals IPO and Indus Net Technologies IPO is , and , respectively.
GNH India Pharmaceuticals IPO P/E ratio is , as compared to Indus Net Technologies IPO P/E ratio of .
| GNH India Pharmaceuticals IPO | Indus Net Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 96.24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 22.99 | 10.53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.49 | 19.57 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 16.81 | 15.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the GNH India Pharmaceuticals IPO Retail Individual Investors (RII) are offered 0 shares while in Indus Net Technologies IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in GNH India Pharmaceuticals IPO and 0 shares in Indus Net Technologies IPO.
| GNH India Pharmaceuticals IPO | Indus Net Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
GNH India Pharmaceuticals IPO subscribed in total, whereas Indus Net Technologies IPO subscribed .
